These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 4273616)

  • 41. [Features of isoniazid activation in patients with tuberculosis and diabetes mellitus].
    Karachunskiĭ MA; Kaminskaia GO; Kossiĭ IuE; Chernykh NA
    Probl Tuberk; 2001; (7):26-7. PubMed ID: 11763557
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients].
    Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895
    [No Abstract]   [Full Text] [Related]  

  • 43. Severe acne due to isoniazid.
    Oliwiecki S; Burton JL
    Clin Exp Dermatol; 1988 Jul; 13(4):283-4. PubMed ID: 2977579
    [No Abstract]   [Full Text] [Related]  

  • 44. [Isoniazid--essential facts and recent advances].
    Zierski M; Rotermund C
    Prax Klin Pneumol; 1984 Jun; 38(6):201-16. PubMed ID: 6382240
    [No Abstract]   [Full Text] [Related]  

  • 45. Isoniazid-induced pellagra despite vitamin-B6 supplementation.
    Bender DA; Russell-Jones R
    Lancet; 1979 Nov; 2(8152):1125-6. PubMed ID: 91851
    [No Abstract]   [Full Text] [Related]  

  • 46. Classification of subjects as slow or rapid inactivators of isoniazid, based on the ratio of the urinary excretion of acetylisoniazid to isoniazid.
    Venkataraman P; Menon NK; Nair NG; Radhakrishna S; Ross C; Tripathy SP
    Tubercle; 1972 Jun; 53(2):84-91. PubMed ID: 5040582
    [No Abstract]   [Full Text] [Related]  

  • 47. [Pellagroid syndrome in a patient treated with isoniazid].
    Polano MK; Abbo AW; Hendrikse JC
    Arch Belg Dermatol Syphiligr; 1969; 25(3):345-8. PubMed ID: 5205153
    [No Abstract]   [Full Text] [Related]  

  • 48. [Effect of insulin on isoniazid and para-aminosalicylic acid metabolism in patients with pulmonary tuberculosis].
    Savula MM; Kiselova ES
    Probl Tuberk; 1974; (8):43-6. PubMed ID: 4409368
    [No Abstract]   [Full Text] [Related]  

  • 49. Isoniazid-induced anaphylaxis.
    Crook MJ
    J Clin Pharmacol; 2003 May; 43(5):545-6. PubMed ID: 12751276
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intermittent chemotherapy of pulmonary tuberculosis using rifampicin and isoniazed for primary treatment: the influence of various factors on the frequency of side-effects.
    Eule H; Werner E; Winsel K; Iwainsky H
    Tubercle; 1974 Mar; 55(1):81-9. PubMed ID: 4470836
    [No Abstract]   [Full Text] [Related]  

  • 51. [Diphenylhydantoin poisoning induced by isoniazide. A further case].
    Beauvais P; Mercier D; Hanoteau J; Brissaud HE
    Arch Fr Pediatr; 1973 May; 30(5):541-6. PubMed ID: 4733654
    [No Abstract]   [Full Text] [Related]  

  • 52. [Isoniazid-induced pleuro-pericarditis].
    Jouneau S; Volatron AC; Brinchault G; Morel V; Belleguic C; Delaval P
    Rev Pneumol Clin; 2003 Dec; 59(6):357-9. PubMed ID: 14745341
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Role of blood proteins in binding and inactivation of HINA].
    Dudchik GKh; bilyk MA
    Probl Tuberk; 1976; 3():52-5. PubMed ID: 967859
    [No Abstract]   [Full Text] [Related]  

  • 54. [On the present status of chemotherapy of lung tuberculosis, especially in ambulatory use].
    Rink H
    Z Tuberk Erkr Thoraxorg; 1967 Apr; 126(1):1-12. PubMed ID: 5631774
    [No Abstract]   [Full Text] [Related]  

  • 55. A comparative study on short course chemotherapy in sputum negative pulmonary tuberculosis.
    Jittinandana A; Kecharanantana P
    J Med Assoc Thai; 1984 Aug; 67(8):429-31. PubMed ID: 6084041
    [No Abstract]   [Full Text] [Related]  

  • 56. Isoniazid-induced hallucinosis: response to pyridoxine.
    Gnam W; Flint A; Goldbloom D
    Psychosomatics; 1993; 34(6):537-9. PubMed ID: 8284347
    [No Abstract]   [Full Text] [Related]  

  • 57. [Clinical significance of the inactivation of tubazid in the endobronchial method of treatment of destructive pulmonary tuberculosis].
    Kanevskaia SS; Rzhavskov IuV
    Probl Tuberk; 1967; 45(10):44-8. PubMed ID: 5617546
    [No Abstract]   [Full Text] [Related]  

  • 58. Drug-induced acne.
    Kazandjieva J; Tsankov N
    Clin Dermatol; 2017; 35(2):156-162. PubMed ID: 28274352
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Letter: Gynecomastia caused by isoniazid. Value of determination of the inactivation phenotype].
    Bergogne-Berezin E; Nouhouayi A; Letonturier P; Thibault B; Tourneur R
    Nouv Presse Med; 1976 Jan; 5(4):213-4. PubMed ID: 1264675
    [No Abstract]   [Full Text] [Related]  

  • 60. [Distribution and elimination of isoniazid-H3 in pulmonary tuberculosis patients].
    Bondarev IM; Vasil'ev NA; Cherednichenko LP
    Probl Tuberk; 1970; 48(3):65-9. PubMed ID: 5453153
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.